These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28783972)

  • 1. Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research.
    Grady C; Bedarida G; Sinaii N; Gregorio MA; Emanuel EJ
    Clin Trials; 2017 Oct; 14(5):526-536. PubMed ID: 28783972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 1 healthy volunteer willingness to participate and enrollment preferences.
    Chen SC; Sinaii N; Bedarida G; Gregorio MA; Emanuel E; Grady C
    Clin Trials; 2017 Oct; 14(5):537-546. PubMed ID: 28766409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The motivations, barriers, and sociodemographic characteristics of healthy Chinese volunteers in phase I research.
    Wang Z; Chen G; Liu X; Liu C; Song Q; Wang J
    Eur J Clin Pharmacol; 2021 Apr; 77(4):557-568. PubMed ID: 33188452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More than the money: a review of the literature examining healthy volunteer motivations.
    Stunkel L; Grady C
    Contemp Clin Trials; 2011 May; 32(3):342-52. PubMed ID: 21146635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial compensation: How much do healthy volunteers actually earn from clinical trial enrollment?
    Fisher JA; McManus L; Kalbaugh JM; Walker RL
    Clin Trials; 2021 Aug; 18(4):477-487. PubMed ID: 33938244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study.
    Fisher JA; McManus L; Cottingham MD; Kalbaugh JM; Wood MM; Monahan T; Walker RL
    PLoS Med; 2018 Nov; 15(11):e1002698. PubMed ID: 30457992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why healthy subjects volunteer for phase I studies and how they perceive their participation?
    Almeida L; Azevedo B; Nunes T; Vaz-da-Silva M; Soares-da-Silva P
    Eur J Clin Pharmacol; 2007 Nov; 63(11):1085-94. PubMed ID: 17891536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.
    Cattapan A; Browne K; Halperin DM; Di Castri A; Fullsack P; Graham J; Langley JM; Taylor BA; McNeil SA; Halperin SA
    Vaccine; 2019 Jan; 37(2):289-295. PubMed ID: 30528592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthy Volunteers' Perceptions of the Benefits of Their Participation in Phase I Clinical Trials.
    Fisher JA; McManus L; Wood MM; Cottingham MD; Kalbaugh JM; Monahan T; Walker RL
    J Empir Res Hum Res Ethics; 2018 Dec; 13(5):494-510. PubMed ID: 30296882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Study on the Characteristics of Healthy Volunteers who Participate in Phase I Clinical Trials in Korea.
    Seo JH; Kim OJ; Yoo SH; Choi EK; Park JE
    J Empir Res Hum Res Ethics; 2022; 17(1-2):193-212. PubMed ID: 34414819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Picking and Choosing Among Phase I Trials : A Qualitative Examination of How Healthy Volunteers Understand Study Risks.
    Fisher JA; Monahan T; Walker RL
    J Bioeth Inq; 2019 Dec; 16(4):535-549. PubMed ID: 31713712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To report or not to report: Exploring healthy volunteers' rationales for disclosing adverse events in Phase I drug trials.
    McManus L; Fisher JA
    AJOB Empir Bioeth; 2018; 9(2):82-90. PubMed ID: 29693508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Credibility and comprehension of healthy volunteers in lengthy inpatient drug studies.
    Apseloff G; Kitzmiller JP; Tishler CL
    Am J Ther; 2013; 20(3):257-60. PubMed ID: 23656966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socio-demographic and fertility-related characteristics and motivations of oocyte donors in eleven European countries.
    Pennings G; de Mouzon J; Shenfield F; Ferraretti AP; Mardesic T; Ruiz A; Goossens V
    Hum Reprod; 2014 May; 29(5):1076-89. PubMed ID: 24626802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Influencing Participation Of Healthy Volunteers In Clinical Trials: Findings From A Cross-Sectional Study In Delhi, North India.
    Ranjan R; Agarwal NB; Kapur P; Marwah A; Parveen R
    Patient Prefer Adherence; 2019; 13():2007-2015. PubMed ID: 31819382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of gender on the decision to participate in a clinical trial: a cross-sectional study.
    Lobato L; Bethony JM; Pereira FB; Grahek SL; Diemert D; Gazzinelli MF
    BMC Public Health; 2014 Nov; 14():1156. PubMed ID: 25377601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitative study investigating the underlying motivations of healthy participants in phase I clinical trials.
    Manton KJ; Gauld CS; White KM; Griffin PM; Elliott SL
    BMJ Open; 2019 Jan; 9(1):e024224. PubMed ID: 30647042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trials.
    Hoogerwerf MA; de Vries M; Roestenberg M
    BMJ Open; 2020 Jul; 10(7):e033796. PubMed ID: 32713843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recruitment of normal healthy volunteers: a review of the literature on the use of financial incentives.
    Tishler CL; Bartholomae S
    J Clin Pharmacol; 2002 Apr; 42(4):365-75. PubMed ID: 11936560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time.
    Kalbaugh CA; Kalbaugh JM; McManus L; Fisher JA
    PLoS One; 2021; 16(9):e0256994. PubMed ID: 34492044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.